Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease. A cancer and acute leukemia group B study (Q41612867)

5 October 2017

title

Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease. A cancer and acute leukemia group B study (English)

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

1 reference

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

author name string

B. Hoogstraten

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

O. Glidewell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

J. F. Holland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

J. Blom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

L. Stutzman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

N. I. Nissen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

H. J. Perlberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

S. Kramer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A445326

2 July 2022

language of work or name

English

0 references

publication date

1 April 1979

1 reference

full work available at URL

5 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

1 reference

5 October 2017

volume

43

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

1234-1244

1 reference

Radiation doses following intensive chemotherapy in the treatment of Hodgkin's disease

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197904%2943%3A4%3C1234%3A%3AAID-CNCR2820430411%3E3.0.CO%3B2-5

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

21 January 2018

6

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Herpes Zoster-Varicella infections and lymphoma

14 May 2023

7

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Hematologic recovery and deterioration after "successful" radiotherapy for Hodgkin's disease

14 May 2023

10

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

The management of Hodgkin's disease

14 May 2023

12

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Correlation of histopathology with other prognostic indicators in Hodgkin's disease

14 May 2023

13

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation

14 May 2023

14

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Splenectomy in Hodgkin's disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy

14 May 2023

15

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report

14 May 2023

16

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Splenectomy Effects on Chemotherapy in Hodgkin's Disease

14 May 2023

17

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Long term remissions with combined modality therapy for advanced Hodgkin's disease

14 May 2023

20

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy

14 May 2023

22

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease

14 May 2023

23

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

Effect of prior splenectomy on hematologic tolerance during total lymphoid radiotherapy of patients with Hodgkin's disease

14 May 2023

24

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

27

31

1801

Tubiana

1971

1 reference

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1234::AID-CNCR2820430411%3E3.0.CO;2-5

14 May 2023

Identifiers

10.1002/1097-0142(197904)43:4<1234::AID-CNCR2820430411>3.0.CO;2-5

1 reference

5 October 2017

1 reference